Skip to main content
. Author manuscript; available in PMC: 2014 Jan 24.
Published in final edited form as: J Am Coll Surg. 2012 May 26;215(3):412–417. doi: 10.1016/j.jamcollsurg.2012.04.023

Table 3. Median Survival Based on Primary and Resection Status after First and Second Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy.

First HIPEC Range Second HIPEC Range
Appendix (all) (n=33) 85.3 11.5-148.5 52.1 0.1-111.7
Low grade (appendix) (n=28) 108.5 11.5-148.5 71.3 0.1-111.7
Mesothelioma (n=7) 52.9 10.7-67.7 21.8 3.1-44.1
Ovarian (n=8) 60.1 15.8-111.4 53.9 0.6+-106.1
Colon (n=4) 137.4 13.6-164.6 55.7 0.3-110.2
R0/1 77.6 7.8-148.5 55.7 0.3+-111.7
R2a 63.5 9.5+-164.6 20.3 0.6+-71.3
R2b 60.3 11.5-71.0 46.8 1.3-84.1
R2c 12.3 10.7-21.0 4.7 0.1-27.7

Based on type of malignancy and resection status, units in months.

HIPEC, hyperthermic intraperitoneal chemotherapy.